Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom
Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom
About this item
Full title
Author / Creator
Publisher
Oxford: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Oxford: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Aims
Continuous‐flow left ventricular assist devices (LVADs) as destination therapy (DT) are a recommended treatment by National Institute for Health and Care Excellence England for end‐stage heart failure patients ineligible for cardiac transplantation. Despite the fact that DT is frequently used as an LVAD indication across other major Europea...
Alternative Titles
Full title
Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ca3d8120b593478db3d145f7b0a24991
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ca3d8120b593478db3d145f7b0a24991
Other Identifiers
ISSN
2055-5822
E-ISSN
2055-5822
DOI
10.1002/ehf2.13401
